Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Gargi Ganguly,1 Sasanka Chakrabarti,2 Uttara Chatterjee,1 Luciano Saso3 1Department of Pathology, Institute of Post Graduate Medical Education and Research, Kolkata, 2Department of Biochemistry, ICARE Institute of Medical Sciences and Research, Haldia, West Bengal, India; 3Department of Physiology...

Full description

Bibliographic Details
Main Authors:	Ganguly G, Chakrabarti S, Chatterjee U, Saso L
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-03-01
Series:	Drug Design, Development and Therapy
Subjects:	proteinopathy amyloid beta oxidative stress α-Synuclein mitochondrial dysfunction.
Online Access:	https://www.dovepress.com/proteinopathy-oxidative-stress-and-mitochondrial-dysfunction-cross-tal-peer-reviewed-article-DDDT

Similar Items

Altered Mitochondrial Protein Homeostasis and Proteinopathies
by: Aya Jishi, et al.
Published: (2022-04-01)

The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
by: Isabel Ubeda-Bañon, et al.
Published: (2020-06-01)

Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
by: Chanchal Sharma, et al.
Published: (2021-07-01)

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
by: Anna Picca, et al.
Published: (2021-10-01)

Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration
by: Amit Shrestha, et al.
Published: (2015-11-01)

Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
by: Fiona Limanaqi, et al.
Published: (2020-04-01)

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
by: Chantal B. Lucini, et al.
Published: (2021-04-01)

The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy
by: Ryszard Pluta
Published: (2023-09-01)

Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer’s disease with cerebrovascular disease
by: Xavier Gallart-Palau, et al.
Published: (2017-09-01)

Organotypic brain slice cultures to model neurodegenerative proteinopathies
by: C. L. Croft, et al.
Published: (2019-12-01)

Amyloid β Modification: A Key to the Sporadic Alzheimer's Disease?
by: Evgeny P. Barykin, et al.
Published: (2017-05-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Salivary levels of disease-related biomarkers in the early stages of Parkinson’s and Alzheimer’s disease: A cross-sectional study
by: Masoomeh Sabaei, et al.
Published: (2023-06-01)

The Binding of Different Substrate Molecules at the Docking Site and the Active Site of γ-Secretase Can Trigger Toxic Events in Sporadic and Familial Alzheimer’s Disease
by: Željko M. Svedružić, et al.
Published: (2023-01-01)

Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
by: Ryszard Pluta, et al.
Published: (2023-07-01)

From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer’s and Parkinson’s diseases
by: Debia Wakhloo, et al.
Published: (2022-01-01)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
by: Zvěřová M
Published: (2018-07-01)

Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer’s disease and other proteinopathies
by: Pablo Mohaupt, et al.
Published: (2023-10-01)

Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC
by: Pierpaolo Risiglione, et al.
Published: (2021-05-01)

The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?
by: Lynette M. Bustos, et al.
Published: (2023-02-01)

Identification and Analysis of Axolotl Homologs for Proteins Implicated in Human Neurodegenerative Proteinopathies
by: Lucas M. James, et al.
Published: (2024-02-01)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
by: Anushka Chakravorty, et al.
Published: (2019-11-01)

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
by: Abolaji Samson Olagunju, et al.
Published: (2023-03-01)

Neurodegenerative diseases as proteinopathies-driven immune disorders
by: Fausta Ciccocioppo, et al.
Published: (2020-01-01)

Editorial: Oligomers in amyloid-associated diseases—structural properties and toxicity
by: Neville Vassallo, et al.
Published: (2023-06-01)

Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein
by: Zuzana Krejciova, et al.
Published: (2019-05-01)

Mechanisms of TDP-43 Proteinopathy Onset and Propagation
by: Han-Jou Chen, et al.
Published: (2021-06-01)

Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
by: Laura Ibanez, et al.
Published: (2020-11-01)

Editorial: Translational imaging in neurodegenerative proteinopathies
by: Ruiqing Ni, et al.
Published: (2022-07-01)

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
by: Martin T. Henrich, et al.
Published: (2023-11-01)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
by: Jiajun Han, et al.
Published: (2021-10-01)

Long noncoding RNAs and Alzheimer's disease
by: Luo Q, et al.
Published: (2016-06-01)

Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection
by: Thomas Nury, et al.
Published: (2020-04-01)

Network based biomarkers in Alzheimer's disease: review and future directions
by: Jaime eGomez-Ramirez, et al.
Published: (2014-02-01)

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
by: Scarlet eGallegos, et al.
Published: (2015-03-01)

Drosophila melanogaster as a model to study autophagy in neurodegenerative diseases induced by proteinopathies
by: Stefania Santarelli, et al.
Published: (2023-05-01)

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease
by: Ilaria eCanobbio, et al.
Published: (2015-03-01)

MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
by: Maximilian Pohland, et al.
Published: (2018-02-01)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
by: Kyu Hwan Shim, et al.
Published: (2022-12-01)

Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies
by: Sean J. Miller, et al.
Published: (2022-06-01)